Asterand plc is the leading global supplier of high quality, well characterized human tissue and human tissue-based research services to drug discovery scientists. Our mission is to provide human tissues and services to accelerate the identification and validation of drug targets and enhance the selection of drug candidates with an increased likelihood of clinical success.
18/05/12
Interim Management Statement02/05/12
Update on Disposals30/04/12
Final Results Statement19/04/12
Notification of Final Results 30 April 201228/03/12
BioSeek Extends Collaboration with Merck Serono06/03/12
Update on Formal Sale Process30/01/12
BioSeek and US EPA Expand ToxCastT Collaboration05/01/12
Update on Formal Sale Process30/11/11
Asterand Reaches Milestone for Ono Drug Discovery18/11/11
Interim Management Statement18/11/11
Update on Formal Sale Process08/11/11
Asterand Receives Contract Extension From NCI07/11/11
Form 8 (OPD) (Asterand PLC)07/11/11
Update on BioSeek Loan Notes26/10/11
Rule 2.10 Announcement25/10/11
Rule 2.10 Announcement24/10/11
Commencement of Formal Sales Process19/10/11
Board Changes - Jonathan Fleming23/09/11
Contract Change31/08/11
Board Changes31/08/11
Interim Results19/08/11
Notification of Interim Results29/07/11
Board Changes13/06/11
CEO Purchase of Shares08/06/11
License agreement with Capsant Neurotechnologies08/06/11
AGM Statement and Proxy Voting Results25/05/11
PDMR Shareholding25/05/11
Issue of Equity17/05/11
Interim Management Statement04/05/11
Notification of Webcast28/04/11
New Financing Arrangements28/04/11
Final Results14/04/11
ISO 9001:2008 Certification05/04/11
Announcement of Final Results31/03/11
Asterand Awarded Key Patents29/03/11
Asterand and 5AM Solutions25/03/11
Major Interest in Shares24/03/11
Major Interest in Shares23/03/11
Notification of Final Results15/03/11
Major Interest in Shares03/03/11
French Tax Credit Accreditation Received09/12/10
Asterand Plc Final Payment for BioSeek Acquisition30/11/10
Asterand PLC Major Interest In Shares30/11/10
Asterand PLC Major Interest In Shares04/11/10
Asterand Plc PDMR Shareholding03/11/10
Asterand Plc Interim Management Statement27/10/10
Asterand Plc Notification of major interests in11/10/10
Asterand Plc Notification of Investor Evening04/10/10
Asterand Plc Grant of Options01/10/10
Asterand Plc National Cancer Institue Contract23/09/10
Asterand Plc BioSeek Signs Agreement with Cellzome22/09/10
Asterand Plc Appointment of Dalia Cohen Ph.D26/08/10
Asterand Plc Interim Results16/08/10
Asterand Plc Notification of Interim Results21/06/10
Asterand Plc Growth Share Ownership Plan14/06/10
Asterand Plc Asterand Signs Agreement with Amylin09/06/10
Asterand Plc Result of AGM09/06/10
Asterand Plc Result of EGM07/06/10
Asterand Plc EPA Extends Asterands Role in ToxCast T Program17/05/10
Asterand Plc John Stchur receives the FD of the year award14/05/10
Asterand Plc Posting of combined circular and notice of EGM13/05/10
Asterand Plc Interim Management Statement10/05/10
Asterand Plc Board Change04/05/10
Asterand Plc Asterand Signs Agreement with Eisai Co.,Ltd22/04/10
Asterand Plc Sponsors of Inaugural Human Tissue Conference31/03/10
Asterand Plc PDMR Share Trading30/03/10
Asterand Plc Preliminary Results23/03/10
Asterand Plc Drug Discovery Collaboration03/03/10
Asterand Plc Notification of Preliminary Results02/03/10
Asterand Plc Notification of Major Interest in01/03/10
Asterand Plc Facility Accepted into Good Laboratory Practice18/02/10
Asterand Plc Completed Acquisition of BioSeek18/02/10
Asterand Plc Completed Acquisition of BioSeek02/02/10
Asterand Plc Posting of combined Circular and Notice of GM02/02/10
Asterand Plc Posting of combined Circular and Notice of GM15/01/10
Asterand Plc Trading Update23/11/09
Asterand Plc Agreement with BMS18/11/09
Asterand Plc Interim Management Statement27/08/09
Asterand Plc Interim Results24/08/09
Asterand Plc Notice of Results20/07/09
Asterand Plc Global agreement with Lundbeck18/06/09
Asterand Plc Piper Jaffray Europe Conference04/06/09
Asterand Plc Result of AGM20/05/09
Asterand Plc Major Interests in Shares14/05/09
Asterand Plc Appointment of Co-Broker14/05/09
Asterand Plc Interim Management Statement12/05/09
Asterand Plc Notification of Major Interest in23/04/09
Asterand Plc Collaborative Agreement to Characterise Antibodies06/04/09
Asterand Plc - Compound licensed to BTG06/04/09
Asterand Plc - Major Interests in Shares
Copyright © Proactiveinvestors.co.uk, 2012. All Rights Reserved Design & Development: Tehnicom Computers
